ArrowMark Colorado Holdings’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,924
| Closed | -$235K | – | 316 |
|
|
2023
Q1 | $235K | Sell |
31,924
-45,344
| -59% | -$333K | ﹤0.01% | 294 |
|
|
2022
Q4 | $516K | Sell |
77,268
-2,496
| -3% | -$16.7K | 0.01% | 268 |
|
|
2022
Q3 | $816K | Sell |
79,764
-108,241
| -58% | -$1.11M | 0.01% | 274 |
|
|
2022
Q2 | $2.29M | Sell |
188,005
-61,011
| -25% | -$743K | 0.03% | 244 |
|
|
2022
Q1 | $5.27M | Sell |
249,016
-78,667
| -24% | -$1.66M | 0.05% | 240 |
|
|
2021
Q4 | $19.7M | Sell |
327,683
-65,242
| -17% | -$3.92M | 0.16% | 125 |
|
|
2021
Q3 | $36.8M | Buy |
392,925
+1,463
| +0.4% | +$137K | 0.29% | 94 |
|
|
2021
Q2 | $32.7M | Sell |
391,462
-8,669
| -2% | -$724K | 0.25% | 103 |
|
|
2021
Q1 | $77.1M | Buy |
+400,131
| New | +$77.1M | 0.58% | 55 |
|